Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1051 to 1065 of 1079 results for infections

  1. Supporting the health and care system to implement virtual wards

    Virtual wards (also known as hospital at home) provide hospital level care at home.

  2. Past research and projects

    NICE's past research and projects

  3. Strengthen the role and impact of ill health prevention

    The Marmot Review summarised the importance the impact of addressing inequalities in health in later life and investing in the early years to preventing ill health later in life.

  4. Enable all children, young people and adults to maximise their capabilities and have control over their lives

    The Marmot Review described the graded relationship between socioeconomic position and educational outcomes and the associations with health and other outcomes in later life.

  5. Key question: safe

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  6. Key question: effective

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  7. NICE leads the way in approving breakthrough treatment for multiple myeloma

    People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year.

  8. Cost saving guidance

    technologies guidance on Leukomed Sorbact for preventing surgical site infection (MTG55) Savings are based on a comparison to standard...

  9. Updated pneumonia guidelines for babies and children with mild pneumonia

    Babies and children between the ages of three months and 11-years-old with pneumonia should be offered a three-day rather than five-day course of antibiotics, according to a new draft NICE guideline.

  10. First licensed treatment for ultra-rare immune disorder recommended

    Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) licensed for use in the NHS in England.

  11. Improvements for people with acute kidney injury in updated quality standard

    An updated quality standard published today (23 March 2023) by NICE outlines improvements in care for people who have or are at risk of acute kidney injury.

  12. Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance

    NHS may use innovative tests which may help people with a urinary tract infection (UTI) receive the correct course of antibiotics more quickly.

  13. People with an acute respiratory infection offered monitoring from home

    People with an acute respiratory infection (ARI) could be monitored from their own homes using technology platforms that will feedback vital information on their condition to clinical staff

  14. Two technologies to provide digital services for people with COPD

    More people with chronic obstructive pulmonary disease (COPD) could soon access rehabilitation programmes after draft guidance from NICE conditionally recommended two technologies to provide digital services to NHS patients.

  15. Thousands could benefit from treatment for severe alopecia

    New one-a-day tablet for people with severe hair loss due to alopecia areata recommended by NICE